InvestorsHub Logo
Followers 52
Posts 5535
Boards Moderated 0
Alias Born 07/03/2020

Re: None

Thursday, 02/11/2021 5:24:10 PM

Thursday, February 11, 2021 5:24:10 PM

Post# of 468719
At the end Missling said he considered the 2b/3 AD trial as "pivotal." That would only be possible if it were to have a strongly clinically meaningful effect.

Really good call. Q&A ran 33 minutes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News